High-risk human papillomavirus (hr-HPV) testing for primary cervical precancer screening
offers an opportunity to improve screening in low-middle income countries (LMICs). This study …

Background Across Ghana, females comprise 1.2% of the entire prison population (n= 15,463).
Cervical cancer screening services are however nonexistent and the prevalence of high-…

Background The need for cervical cancer screening has been emphasised in at-risk cohorts
of women to reduce their risk of cervical cancer. Some women with decreased risk of …

Cytology-based cervical cancer screening programs have been difficult to implement and
scale up in developing countries. Thus, the World Health Organization recommends a ‘see …

Though cervical cancer is largely preventable, success depends on sustained screening
and treatment of precancer. This is not available in many low resource settings where …

Evidence of the impact of public reporting of health care performance on quality improvement
is not yet sufficient for definitive conclusions to be drawn, despite the important policy …

In response to calls by the World Health Organization for cervical precancer screening services
in low-resource settings to lean toward HPV DNA testing, a number of testing platforms …

Background Worldwide, about 20–25 million people are affected by sickle cell disease (SCD),
with 60% of patients living in sub-Saharan Africa. Despite recent therapeutic …

Methods We applied quality guidelines to all PAP smear diagnoses of high-grade squamous
intraepithelial lesion (HSIL) at Catholic Hospital Battor from 1 June 2016 to 31 August 2021…

Abstract: Over 260,000 women die yearly from cervical cancer, mostly in low and middle-income
countries. Molecular testing for high-risk Human Papilloma Virus (HPV) is now the …